ConductScience.org, home

Paper8599877

Effects of granisetron with doxorubicin or epirubicin on ECG intervals.

Jantunen IT and 3 others. Cancer Chemother Pharmacol, 1996. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Effects of granisetron with doxorubicin or epirubicin on ECG intervals. Papers, record 8599877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8599877

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of granisetron with doxorubicin or epirubicin on ECG intervals.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2026-01-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jantunen ITI T
2Kataja VVV V
3Muhonen TTT T
4Parviainen TT

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntiemeticsMajor topic
DoxorubicinMajor topic
ElectrocardiographyMajor topic
EpirubicinMajor topic
GranisetronMajor topic
Adult
Aged
Antibiotics, Antineoplastic
Drug Interactions
Female
Heart Rate
Humans
Injections, Intravenous
Male
Middle Aged
Neoplasms
Serotonin Antagonists

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18120559A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.J Clin Oncol1994https://conductscience.org/library/papers/8120559PubMed
21678781Cardiac disturbances during the administration of taxol.J Clin Oncol1991https://conductscience.org/library/papers/1678781PubMed
32466960Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.J Clin Oncol1989https://conductscience.org/library/papers/2466960PubMed
42169778The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.Eur J Cancer1990https://conductscience.org/library/papers/2169778PubMed
58164028Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin.J Clin Oncol1994https://conductscience.org/library/papers/8164028PubMed
6291473Sudden death during doxorubicin administration.Cancer1979https://conductscience.org/library/papers/291473PubMed
71985170Cisplatin-induced atrial fibrillation.J Clin Oncol1991https://conductscience.org/library/papers/1985170PubMed
81855280Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1855280PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
25834466Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.Cancer Manag Res2015https://conductscience.org/library/papers/25834466PubMed
24790242
An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the fda combined spontaneous reporting system/adverse event reporting system.
Curr Ther Res Clin Exp2005https://conductscience.org/library/papers/24790242PubMed
24741326A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation.Cancer Manag Res2014https://conductscience.org/library/papers/24741326PubMed
23716765Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial.Indian J Anaesth2013https://conductscience.org/library/papers/23716765PubMed
22241602Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial.Support Care Cancer2012https://conductscience.org/library/papers/22241602PubMed
22170340Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study.Support Care Cancer2012https://conductscience.org/library/papers/22170340PubMed
21773677Electrocardiographic findings of palonosetron in cancer patients.Support Care Cancer2012https://conductscience.org/library/papers/21773677PubMed
21356241Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.Pharmacol Ther2011https://conductscience.org/library/papers/21356241PubMed
18239945The acute effect of tropisetron on ECG parameters in cancer patients.Support Care Cancer2008https://conductscience.org/library/papers/18239945PubMed
12608887Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.Drug Saf2003https://conductscience.org/library/papers/12608887PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8599877

GET https://conductscience.org/api/papers/v1/8599877/authors